Release Date: 27/10/10 08:22 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 14.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%